 |
| |
Neurogen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Neurogen Corporation (Neurogen) is a biopharmaceutical company focused on the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company is offering a wide range of new drug programs through its fully integrated drug discovery and development programs. Its lead clinical development programs are in Parkinson's disease and Restless legs syndrome (RLS). The company also has other potential opportunities including GABAA, VR1 and P2X7. It is headquartered at Branford in Connecticut, United States
The Neurogen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Neurogen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=KWK0Y64UP166682
|
—
